Household Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.46 Cr
as on 16-11-2024
- Company Age 30 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.68 Cr
as on 16-11-2024
- Satisfied Charges ₹ 3.34 Cr
as on 16-11-2024
- Revenue 66.94%
(FY 2023)
- Profit 53.83%
(FY 2023)
- Ebitda 21.21%
(FY 2023)
- Net Worth 6.37%
(FY 2023)
- Total Assets 35.73%
(FY 2023)
About Household Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.46 Cr.
The company currently has active open charges totaling ₹2.68 Cr. The company has closed loans amounting to ₹3.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhupendra Kukreja, Kamal Kukreja, Suniya Kukreja, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH1994PLC076735
- Company No.
076735
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Feb 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Household Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhupendra Kukreja  | Director | 01-Jul-2008 | Current |
| Kamal Kukreja | Director | 01-Apr-2012 | Current |
| Suniya Kukreja | Director | 15-Sep-2009 | Current |
| Sanjay Cheturam | Director | 25-Mar-2009 | Current |
Financial Performance and Corporate Structure Insights of Household Pharmaceuticals.
Household Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 66.94% increase. The company also saw a substantial improvement in profitability, with a 53.83% increase in profit. The company's net worth moved up by a moderate rise of 6.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Household Pharmaceuticals?
In 2023, Household Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adroit Pharmaceuticals Private LimitedActive 47 years 7 monthsBhupendra Kukreja and Sanjay Cheturam are mutual person
- Haseeb Pharmaceuticals Private LimitedActive 25 years 8 months
Bhupendra Kukreja and Sanjay Cheturam are mutual person
- Heil German Pharmaceuticals Private LimitedActive 14 years 1 month
Bhupendra Kukreja and Sanjay Cheturam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Nagpur Nagarik Sahakari Bank Limited Creation Date: 25 Sep 2013 | ₹1.74 Cr | Open |
Bank Of Maharashtra Creation Date: 30 Apr 2011 | ₹9.40 M | Open |
Syndicate Bank Creation Date: 29 Mar 2007 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Household Pharmaceuticals?
Unlock and access historical data on people associated with Household Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Household Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Household Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
